Follow
Tommi Tervonen
Tommi Tervonen
Chief Scientist at Kielo Research
Verified email at kieloresearch.com
Title
Cited by
Year
A data model for algorithmic multiple criteria decision analysis
O Cailloux, T Tervonen, B Verhaegen, F Picalausa
Annals of Operations Research 217, 77-94, 2014
62014
A discrete choice experiment to assess patient preferences for asthma rescue therapy and disease management
E Israel, N Farooqui, C Gillette, I Gilbert, H Gandhi, T Tervonen, ...
The Journal of Allergy and Clinical Immunology: In Practice 11 (9), 2781 …, 2023
42023
A method for elicitating and combining group preferences for stochastic multicriteria acceptability analysis
T Tervonen, R Lahdelma, P Salminen
Turku Centre for Computer Science, 2004
192004
A multi-criteria decision analysis approach for prioritization of performance metrics: US Government Performance and Response Act and oil spill response
I Linkov, FK Satterstrom, A Tkachuk, A Levchenko, TP Seager, ...
Managing Critical Infrastructure Risks: Decision Tools and Applications for …, 2007
172007
A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions
D Postmus, T Tervonen, G van Valkenhoef, HL Hillege, E Buskens
The European Journal of Health Economics 15, 709-716, 2014
262014
A multi-criteria inference approach for anti-desertification management
T Tervonen, A Sepehr, M Kadziński
Journal of Environmental Management 162, 9-19, 2015
282015
A QUANTITATIVE BENEFIT-RISK ASSESSMENT BY APPLYING THE PRINCIPLES OF THE EUROPEAN MEDICINES AGENCY BENEFIT RISK ASSESSMENT FRAMEWORK AND THE PUBLICLY AVAILABLE, OPEN SOURCE …
H Hillege, D Postmus, T Tervonen, Q Ataher
ISPOR Europe 2019, 2019
2019
A simulated maximum likelihood procedure for analyzing imprecise trade‐off thresholds between the benefits and harms of medicines
D Postmus, F Pignatti, HL Hillege, T Tervonen
Statistics in Medicine 41 (29), 5612-5621, 2022
22022
A state-of-the-art multi-criteria model for drug benefit-risk analysis
D Postmus, E Buskens, HL Hillege, T Tervonen
Research Report, 2010
2010
A state-of-the-art multi-criteria model for drug benefit-risk analysis
HL Hillege, E Buskens, D Postmus, T Tervonen
Research Report, 2010
32010
A state-of-the-art multi-criteria model for drug benefit-risk analysis
T Tervonen, HL Hillege, E Buskens, D Postmus
82010
A stochastic method for robustness analysis in sorting problems
T Tervonen, JR Figueira, R Lahdelma, JA Dias, P Salminen
European Journal of Operational Research 192 (1), 236-242, 2009
2282009
A stochastic multicriteria model for evidence‐based decision making in drug benefit‐risk analysis
T Tervonen, G Van Valkenhoef, E Buskens, HL Hillege, D Postmus
Statistics in Medicine 30 (12), 1419-1428, 2011
1382011
A survey on stochastic multicriteria acceptability analysis methods
T Tervonen, JR Figueira
Journal of Multi‐Criteria Decision Analysis 15 (1‐2), 1-14, 2008
2892008
A systematic and critical review of discrete choice experiments in asthma and chronic obstructive pulmonary disease
H Collacott, D Zhang, S Heidenreich, T Tervonen
The Patient-Patient-Centered Outcomes Research 15, 55-68, 2022
102022
ADDIS: a decision support system for evidence-based medicine
G Van Valkenhoef, T Tervonen, T Zwinkels, B De Brock, H Hillege
Decision Support Systems 55 (2), 459-475, 2013
2532013
Algorithmic parameterization of mixed treatment comparisons
G van Valkenhoef, T Tervonen, B de Brock, H Hillege
Statistics and Computing 22, 1099-1111, 2012
372012
AN APPROACH FOR MODELLING PREFERENCES OF MULTIPLE DECISION MAKERS
T Tervonen, J Figueira, R Lahdelma, P Salminen, T Honkela, M Kononen, ...
Proceedings of the Interdisciplinary Conference on Adaptive Knowledge …, 2005
12005
An inverse analysis of ELECTRE III
J Figueira, T Tervonen, R Lahdelma, P Salminen
IFORS 2005, 2005
42005
An inverse approach for ELECTRE III
T Tervonen, J Figueira, R Lahdelma, P Salminen
Instituto de Engenharia de Sistemas e Computadores de Coimbra, 2004
292004
The system can't perform the operation now. Try again later.
Articles 1–20